Search Results

There are 97700 results for: content related to: Effects of Statins on Progression of Coronary Artery Disease as Measured by Intravascular Ultrasound

  1. You have full text access to this Open Access content
    Short-Term Treatment with High-Dose Atorvastatin Reduces LDL Cholesterol but Shows no Anti-Inflammatory Effects in Normolipidemic Subjects with Normal CRP Levels

    Clinical and Translational Science

    Volume 3, Issue 4, August 2010, Pages: 140–146, John S. Millar, Bonnie Ky, Megan L. Wolfe, Leticia Pruscino, Amanda Baer and Daniel J. Rader

    Version of Record online : 18 AUG 2010, DOI: 10.1111/j.1752-8062.2010.00211.x

  2. You have free access to this content
    Effects of lamotrigine and phenytoin on the pharmacokinetics of atorvastatin in healthy volunteers

    Epilepsia

    Volume 52, Issue 7, July 2011, Pages: 1351–1358, Jonathan Bullman, Andrew Nicholls, Kevan Van Landingham, Richard Fleck, Alain Vuong, James Miller, Sarah Alexander and John Messenheimer

    Version of Record online : 2 JUN 2011, DOI: 10.1111/j.1528-1167.2011.03118.x

  3. You have free access to this content
    Most appropriate animal models to study the efficacy of statins: a systematic review

    European Journal of Clinical Investigation

    Volume 44, Issue 9, September 2014, Pages: 848–871, Valentina Pecoraro, Lorenzo Moja, Luigi Dall'Olmo, Glauco Cappellini and Silvio Garattini

    Version of Record online : 28 AUG 2014, DOI: 10.1111/eci.12304

  4. The Role of Statins in Reversing Atherosclerosis: What the Latest Regression Studies Show

    Journal of Interventional Cardiology

    Volume 19, Issue 1, February 2006, Pages: 3–9, CINDY L. GRINES

    Version of Record online : 15 FEB 2006, DOI: 10.1111/j.1540-8183.2006.00097.x

  5. You have free access to this content
    Update on the efficacy of statin treatment in acute coronary syndromes

    European Journal of Clinical Investigation

    Volume 44, Issue 5, May 2014, Pages: 501–515, Gian Marco Rosa, Federico Carbone, Antonello Parodi, Elena A. Massimelli, Claudio Brunelli, François Mach, Nicola Vuilleumier and Fabrizio Montecucco

    Version of Record online : 17 APR 2014, DOI: 10.1111/eci.12255

  6. Effect of OATP1B Transporter Inhibition on the Pharmacokinetics of Atorvastatin in Healthy Volunteers

    Clinical Pharmacology & Therapeutics

    Volume 81, Issue 2, February 2007, Pages: 194–204, Y Y Lau, Y Huang, L Frassetto and L Z Benet

    Version of Record online : 27 DEC 2006, DOI: 10.1038/sj.clpt.6100038

  7. Effect of Gemfibrozil and Fenofibrate on the Pharmacokinetics of Atorvastatin

    The Journal of Clinical Pharmacology

    Volume 51, Issue 3, March 2011, Pages: 378–388, Dr Lloyd R. Whitfield, Dr Anthony R. Porcari, Ms Christine Alvey, Dr Robert Abel, Mr William Bullen and Dr Daniel Hartman

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010366446

  8. You have free access to this content
    Effects of atorvastatin on systemic and renal NO dependency in patients with non-diabetic stage II–III chronic kidney disease

    British Journal of Clinical Pharmacology

    Volume 78, Issue 4, October 2014, Pages: 789–799, Frank Holden Mose, Thomas Larsen, Janni Majgaard Jensen, Annebirthe Bo Hansen, Jesper Nørgaard Bech and Erling Bjerregaard Pedersen

    Version of Record online : 19 SEP 2014, DOI: 10.1111/bcp.12390

  9. Pharmacologic Therapy for Nonalcoholic Fatty Liver Disease in Adults

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 33, Issue 2, February 2013, Pages: 223–242, Scott S. Malinowski, Jennifer S. Byrd, Allison M. Bell, Marion R. Wofford and Daniel M. Riche

    Version of Record online : 28 JAN 2013, DOI: 10.1002/phar.1190

  10. You have free access to this content
    Cholesterol-lowering effects of rosuvastatin compared with atorvastatin in patients with type 2 diabetes – CORALL study

    Journal of Internal Medicine

    Volume 257, Issue 6, June 2005, Pages: 531–539, B. H. R. WOLFFENBUTTEL, A. A. M. FRANKEN, H. H. VINCENT and THE DUTCH CORALL STUDY GROUP

    Version of Record online : 23 MAY 2005, DOI: 10.1111/j.1365-2796.2005.01499.x

  11. Statin use and the risk of developing diabetes: a network meta-analysis

    Pharmacoepidemiology and Drug Safety

    Divyesh Thakker, Sunita Nair, Amit Pagada, Vinayak Jamdade and Anuradha Malik

    Version of Record online : 9 JUN 2016, DOI: 10.1002/pds.4020

  12. You have free access to this content
    Effective prevention of cardiovascular disease and diabetes-related events with atorvastatin in Japanese elderly patients with type 2 diabetes mellitus: Adjusting for treatment changes using a marginal structural proportional hazards model and a rank-preserving structural failure time model

    Geriatrics & Gerontology International

    Volume 12, Issue s1, April 2012, Pages: 88–102, Tomohiro Shinozaki, Yutaka Matsuyama, Satoshi Iimuro, Hiroyuki Umegaki, Takashi Sakurai, Atsushi Araki, Yasuo Ohashi, Hideki Ito and the Japanese Elderly Diabetes Intervention Trial Research Group

    Version of Record online : 21 MAR 2012, DOI: 10.1111/j.1447-0594.2011.00816.x

  13. Effects of atorvastatin on oxidative stress in chronic kidney disease

    Nephrology

    Volume 20, Issue 10, October 2015, Pages: 697–705, Robert G Fassett, Iain K Robertson, Madeleine J Ball, Dominic P Geraghty and Jeff S Coombes

    Version of Record online : 11 SEP 2015, DOI: 10.1111/nep.12502

  14. Pharmacokinetics of the Oral Direct Renin Inhibitor Aliskiren in Combination With Digoxin, Atorvastatin, and Ketoconazole in Healthy Subjects: The Role of P-Glycoprotein in the Disposition of Aliskiren

    The Journal of Clinical Pharmacology

    Volume 48, Issue 11, November 2008, Pages: 1323–1338, Dr Sujata Vaidyanathan, Dr Gian Camenisch, Dr Helmut Schuetz, Ms Christine Reynolds, Dr Ching-Ming Yeh, Dr Marie-Noelle Bizot, Dr Hans Armin Dieterich, Dr Dan Howard and Dr William P. Dole

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008323258

  15. You have free access to this content
    Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption

    Biopharmaceutics & Drug Disposition

    Volume 34, Issue 1, January 2013, Pages: 45–78, Yoshihisa Shitara, Kazuya Maeda, Kazuaki Ikejiri, Kenta Yoshida, Toshiharu Horie and Yuichi Sugiyama

    Version of Record online : 20 JAN 2013, DOI: 10.1002/bdd.1823

  16. Comparative effects of rosuvastatin and atorvastatin on glucose metabolism and adipokine levels in non-diabetic patients with dyslipidaemia: a prospective randomised open-label study

    International Journal of Clinical Practice

    Volume 65, Issue 6, June 2011, Pages: 679–683, P. Anagnostis, D. Selalmatzidou, S. A. Polyzos, A. Panagiotou, A. Slavakis, A. Panagiotidou, V. G. Athyros, A. Karagiannis, D. P. Mikhailidis and M. Kita

    Version of Record online : 12 MAY 2011, DOI: 10.1111/j.1742-1241.2011.02655.x

  17. Meta-analysis methods and models with applications in evaluation of cholesterol-lowering drugs

    Statistics in Medicine

    Volume 31, Issue 28, 10 December 2012, Pages: 3597–3616, Ming-Hui Chen, Joseph G. Ibrahim, Arvind K. Shah, Jianxin Lin and Hui Yao

    Version of Record online : 25 JUL 2012, DOI: 10.1002/sim.5462

  18. You have free access to this content
    Antihypertensive Effects of Statins: A Meta-Analysis of Prospective Controlled Studies

    The Journal of Clinical Hypertension

    Volume 15, Issue 5, May 2013, Pages: 310–320, Alexandros Briasoulis, Vikram Agarwal, Antonis Valachis and Franz H. Messerli

    Version of Record online : 7 MAR 2013, DOI: 10.1111/jch.12081

  19. You have free access to this content
    Effect of High-Dose Statin Pretreatment on the Incidence of Periprocedural Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention: Grading the Evidence Through a Cumulative Meta-analysis

    Clinical Cardiology

    Volume 38, Issue 11, November 2015, Pages: 668–678, ChuanNan Zhai, HongLiang Cong, YuJie Liu, Ying Zhang, XianFeng Liu, Hao Zhang and ZhiJing Ren

    Version of Record online : 7 OCT 2015, DOI: 10.1002/clc.22471

  20. EFFECTS OF ATORVASTATIN AND PRAVASTATIN ON GLUCOSE TOLERANCE, ADIPOKINE LEVELS AND INFLAMMATORY MARKERS IN HYPERCHOLESTEROLAEMIC PATIENTS

    Clinical and Experimental Pharmacology and Physiology

    Volume 35, Issue 9, September 2008, Pages: 1012–1017, Hitoshi Ando, Koh-ichi Sugimoto, Hayato Yanagihara, Shuichi Tsuruoka, Tetsuo Saito, Toshinari Takamura, Shuichi Kaneko and Akio Fujimura

    Version of Record online : 21 APR 2008, DOI: 10.1111/j.1440-1681.2008.04945.x